Sanofi Pasteur and Merck Vaccines Appoint David Khougazian as President of Sanofi Pasteur MSD
France (ots/PRNewswire)
MSD, known as Merck in the United States and Canada and Sanofi Pasteur, the vaccines division of Sanofi , the two partner companies in Sanofi Pasteur MSD, announce today the appointment of David Khougazian as president of Sanofi Pasteur MSD.
To view the Multimedia News Release, please click: http://www.multivu.com/players/uk/7563651-david-khougazian-president-sanofi-pasteur/ [http://www.multivu.com/players/uk/7563651-david-khougazian-president-sanofi-pasteur]
On July 1, Khougazian will join Sanofi Pasteur MSD and effective September 1, will succeed Dr. Jean-Paul Kress, who led the company since July 2011. Kress will leave Sanofi Pasteur MSD to join the Sanofi group.
Video: http://www.multivu.com/players/uk/7563651-david-khougazian-president-sanofi-pasteur
Contact:
FleishmanHillard
Marion Cocherel
Tel: +33-1-47-42-91-18
Mob: +33-6-8-56-85-38
Marion.cocherel@fleishman.com
Sanofi Pasteur MSD
Andrea Rappagliosi
Tel: +33-4-37-28-41-71
arappagliosi@spmsd.com